###begin article-title 0
###xml 23 46 23 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNA methyltransferase 1</italic>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways
###end article-title 0
###begin p 1
###xml 95 125 95 125 <email xmlns:xlink="http://www.w3.org/1999/xlink">ashiota@mail.ecc.u-tokyo.ac.jp</email>
To whom correspondence should be addressed. Tel: +81 3 5841 5472; Fax: +81 3 5841 8189; Email: ashiota@mail.ecc.u-tokyo.ac.jp
###end p 1
###begin p 2
###xml 87 95 <span type="species:ncbi:9606">Children</span>
Present addresses: Hiromichi Kimura, Department of Developmental Neurobiology, St Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, USA
###end p 2
###begin p 3
Takahisa Nakamura, Division of Oncology, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
###end p 3
###begin p 4
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 4
###begin p 5
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 219 227 219 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 845 850 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 873 874 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 876 877 876 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1103 1108 1103 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1267 1272 1267 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 160 164 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 368 373 <span type="species:ncbi:10090">mouse</span>
Abnormal expression of Dnmt1 in vivo induces cellular alterations such as transformation, and an increase in Dnmt1 mRNA plays a causal role in c-fos-, ras- and SV40 large T antigen-induced transformation of fibroblasts in vitro. Here, we have investigated the regulation of Dnmt1 transcription. We identified the promoter region and major transcription start sites of mouse Dnmt1 and found two important cis-elements within the core promoter region. One is an E2F binding site, and the other is a binding site for an as yet unidentified factor. Point mutations in the two cis-elements decreased promoter activity in both non-transformed and transformed cells. Thus, both sites play a critical role in regulation of Dnmt1 transcription in proliferating cells. Treatment with trichostatin A, a specific inhibitor of histone deacetylase, increased Dnmt1 promoter activity in G0/G1-arrested NIH 3T3 cells. Furthermore, the decrease in promoter activity induced by expression of E2F-1 and Rb was reversed by trichostatin A treatment of Saos-2 cells. Taken together, these data indicate that transcription of Dnmt1 is regulated in a complex fashion by E2F and other transcription factors through E2F-Rb-HDAC-dependent and -independent pathways. These findings suggest that Dnmt1 is a target gene of these pathways in cell proliferation, cell transformation and tumorigenesis.
###end p 5
###begin p 6
DDBJ/EMBL/GenBank accession nos AB056445, AB056446
###end p 6
###begin title 7
INTRODUCTION
###end title 7
###begin p 8
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c1">1</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c4">4</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c5">5</xref>
In mammalian cells, genomic DNA is methylated on the fifth carbon position of cytosine in CpG dinucleotides, and the distribution of methylated cytosines is cell and tissue specific (1-4). DNA methylation is correlated with gene silencing and condensation of chromatin structure. Inhibition of transcription by DNA methylation occurs either because methyl groups on cytosine limit the access of transcription factors to DNA binding sites or by the recruitment of histone deacetylase (HDAC) via methyl-CpG binding proteins such as MeCP2 (5).
###end p 8
###begin p 9
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c6">6</xref>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c7">7</xref>
###xml 181 189 181 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c8">8</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c9">9</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c10">10</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c11">11</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c12">12</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c10">10</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c13">13</xref>
Patterns of DNA methylation are generated during development by DNA methyltransferases such as Dnmt1 (6,7). Dnmt1 prefers hemi-methylated DNA over non-methylated DNA as a substrate in vitro (8), and expression of Dnmt1 increases during S phase (9,10). Dnmt1 is recruited to replication foci through protein interactions involving the DMAP1 binding region (11), the proliferating cell nuclear antigen (PCNA) binding region (12) and the replication foci targeting sequence (10). We have recently found a direct interaction between Dnmt1 and MeCP2 (13), which may confer accurate maintenance of DNA methylation patterns through stepwise interactions during DNA replication.
###end p 9
###begin p 10
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c14">14</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c15">15</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c16">16</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c16">16</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c17">17</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c17">17</xref>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 646 651 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c18">18</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c17">17</xref>
###xml 1051 1054 1051 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c19">19</xref>
###xml 1072 1077 1072 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 571 580 <span type="species:ncbi:10090">nude mice</span>
###xml 698 701 <span type="species:ncbi:10116">rat</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
Aberrant CpG methylation has been observed in several tumors (14). Some CpG islands are hypermethylated in tumor cells (15,16), suggesting that a fundamental disruption of methylation control has occurred. This aberrant hypermethylation can act in a manner analogous to deletion or mutation of growth inhibitory genes, thereby producing a selective growth advantage (16). Dnmt1 has been shown to act as an oncogene in cultured fibroblasts (17). Further, NIH 3T3 cells transformed by Dnmt1 show enhanced DNA methylation, and these cells form tumors when transplanted into nude mice (17). Conditional expression of c-fos up-regulates expression of Dnmt1, resulting in morphological transformation of rat fibroblasts (18). Interestingly, a low level of Dnmt1 over-expression leads to cell transformation whereas a high level is toxic (17). In addition, s.c. injection of the Dnmt1 inhibitor 5-aza-2'-deoxycytidine decreases polyp number in Min mice that are heterozygous for the multiple intestinal neoplasia mutation of the adenomatosis polyposis coli (Apc) gene (19). Thus Dnmt1 expression must be tightly regulated during normal cell growth.
###end p 10
###begin p 11
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 134 137 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c20">20</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c21">21</xref>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c9">9</xref>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNMT1</italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c22">22</xref>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 829 830 829 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c9">9</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c23">23</xref>
###xml 947 952 947 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 438 443 <span type="species:ncbi:9606">human</span>
The mechanisms responsible for regulation of Dnmt1 transcription are poorly understood. Expression of immediate early genes such as c-fos increases drastically within 1 h after serum stimulation (20,21). However, expression of Dnmt1 mRNA varies in a cell cycle-dependent manner reaching a maximum during S phase (9). These findings suggest that Dnmt1 is controlled not only by c-fos but also by other transcription factors. Expression of human DNMT1 is increased by binding of Jun homodimers or Fos-Jun hetrodimers to a region located between exons 1 and 2 (22). Nuclear run-on assays in BALB/c 3T3 and myoblast G8 cells indicated that the transcriptional activity of Dnmt1 is constant throughout the cell cycle and during cellular differentiation, suggesting that mRNA levels may be modulated at the post-transcriptional level (9,23). These contradictory findings stimulated us to investigate the regulatory mechanisms that control expression of Dnmt1.
###end p 11
###begin p 12
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCNA</italic>
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol</italic>
###xml 84 89 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-1</italic>
###xml 94 98 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc6</italic>
###xml 157 159 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c24">24</xref>
###xml 245 247 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c24">24</xref>
###xml 248 250 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c25">25</xref>
###xml 438 446 434 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
###xml 451 456 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-1</italic>
###xml 481 483 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c26">26</xref>
###xml 484 486 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c27">27</xref>
###xml 506 514 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
###xml 519 523 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p107</italic>
###xml 629 631 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c24">24</xref>
###xml 685 689 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCNA</italic>
###xml 691 696 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-1</italic>
###xml 701 706 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b-Myb</italic>
###xml 764 766 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c28">28</xref>
###xml 346 361 <span type="species:ncbi:10633">simian virus 40</span>
###xml 363 367 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The expression of many replication-related genes, such as PCNA, cyclin E, polalpha, E2F-1 and cdc6, is regulated by the E2F family of transcription factors (24). The transcriptional activity of E2F is controlled by binding of Rb family members (24,25). The Rb/E2F complex is disrupted by Rb kinases (cyclin D/cdk4, cdk6 and cyclin E/cdk2) and by simian virus 40 (SV40) large T antigen, resulting in activation of E2F target genes such as cyclin E and E2F-1 and entry into S phase (26,27). The promoters of cyclin E and p107 contain E2F binding sites, and repression of their expression by Rb has been shown to be HDAC-dependent (24). However, the expression of other E2F target genes, PCNA, E2F-1 and b-Myb, is insensitive to treatment with trichostatin A (TSA). (28). For each E2F target gene, the pathways regulating transcription are classified as either HDAC dependent or independent.
###end p 12
###begin p 13
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
In this study, we focus on the transcriptional regulation of mouse Dnmt1. We demonstrate that transcription of Dnmt1 during cell cycle progression is modulated by two cis-elements in the promoter region. We propose that a combination of E2F-Rb-HDAC-dependent and -independent pathways control Dnmt1 transcription during cell growth.
###end p 13
###begin title 14
MATERIALS AND METHODS
###end title 14
###begin title 15
Cell culture
###end title 15
###begin p 16
###xml 266 272 <span type="species:ncbi:9913">bovine</span>
COS-7 cells, NIH 3T3 cells, 3Y1-B clone 1-6 (RCB 0488), SR-3Y1 (JCRB 0742), HR-3Y1 (JCRB 0743), E1A-3Y1 (JCRB 0738) and SV-3Y1 (JCRB 0735) cells and Saos-2 cells (RCB 0428) were all maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). All culture media were supplemented with 100 U/ml penicillin (Sigma) and 100 microg/ml streptomycin (Sigma).
###end p 16
###begin p 17
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
To bring NIH 3T3 cells to quiescence, 5 x 105 cells were plated on a 150 mm dish and incubated overnight. The next day, the cells were washed three times with phosphate-buffered saline (PBS), and the culture medium was replaced with DMEM containing 0.05% FBS. Cells were incubated for 36 h prior to serum stimulation, then harvested at the indicated time after addition of the complete medium.
###end p 17
###begin title 18
Northern blot analysis
###end title 18
###begin p 19
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c29">29</xref>
###xml 275 284 275 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 286 294 286 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gapdh</italic>
Total RNA was isolated from NIH 3T3 cells with TRIzol (Gibco BRL) according to the manufacturer's instructions. Ten micrograms of total RNA were separated by agarose gel electrophoresis under denaturing conditions and hybridized at high stringency to DIG-labeled Dnmt1 (29), cyclin D1, cyclin E and gapdh antisense RNA probes.
###end p 19
###begin title 20
FACScan analysis
###end title 20
###begin p 21
Cells were detached by incubation with 0.25% trypsin/1 mM EDTA, washed with ice-cold PBS three times and fixed with ice-cold 75% ethanol. Cells were subsequently washed with PBS three times to remove ethanol and were suspended in PBS containing 50 microg/ml propidium iodide. Cell synchrony was assessed by FACScan (Becton Dickinson) and cell cycle distribution was analyzed by using CellQuest software and Modifit LT software (Becton Dickinson).
###end p 21
###begin title 22
Library screening and sequencing
###end title 22
###begin p 23
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c29">29</xref>
###xml 339 340 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 503 506 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 624 626 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c30">30</xref>
###xml 18 21 <span type="species:ncbi:10116">rat</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 311 316 <span type="species:ncbi:10090">mouse</span>
An EcoRI-digested rat Dnmt1 cDNA fragment containing the 5' flanking region (214 bp) including the somatic translation start codon (29) was used to screen a mouse 129/SvJ male kidney lambdaDashII genomic library (a gift from Dr J. Rossant) under high stringency conditions. The probe has >91% homology with the mouse sequence. Among 5 x 105 phages examined, three positive independent clones containing 25, 16 and 16 kb, respectively, of insert DNA fragment were obtained. A 9.6 kb DNA fragment between BamHI sites from the 25 kb fragment was subcloned into pBluescript SK(-) vector and sequenced using a standard protocol (30) (DDBJ accession no. AB056445).
###end p 23
###begin title 24
RNase protection assay
###end title 24
###begin p 25
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
###xml 156 161 <span type="species:ncbi:10090">mouse</span>
Assays were performed by using an RNase Protection kit (Roche) according to the manufacturer's instructions. Two radiolabeled RNA probes were prepared from mouse Dnmt1 DNA fragments. Probe 380 consisted of 300 bases upstream from the translation start codon and 80 bases downstream, and probe 80 contained the 80 bases downstream of the start codon (Fig. 2B). Both fragments were cloned into pGEM-T easy vector (Promega), from which antisense cRNAs were transcribed with SP6 or T7 RNA polymerase. Ten micrograms of total RNA were added to the labeled cRNA probe. The mixture was denatured at 95degreesC for 5 min. Hybridization was performed overnight at 41degreesC. The hybridization reaction was cooled to room temperature and treated with RNase A at 30degreesC for 30 min. Stop solution (0.5% SDS and 0.27 mg/ml proteinase K) was added and the reaction mixture was incubated at 37degreesC for 15 min. RNA was extracted with phenol/chloroform/isoamyl alcohol (25:24:1), and the double-stranded RNA was precipitated with ethanol. It subsequently was subjected to electrophoresis in a 4% polyacrylamide/7 M urea gel in Tris-borate buffer. Signal was detected by using a BAS 2000 image analyzer (Fuji film).
###end p 25
###begin title 26
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 43 46 <span type="species:ncbi:10116">rat</span>
Isolation of the 5' flanking region of the rat Dnmt1
###end title 26
###begin p 27
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 32 35 <span type="species:ncbi:10116">rat</span>
###xml 59 62 <span type="species:ncbi:10116">rat</span>
To identify the sequence of the rat Dnmt1 promoter region, rat oocyte-specific short form Dnmt1 cDNA was amplified from ovary-derived total RNA by RT-PCR using the following primer set: forward primer (1o Dnmt1-F3), 5'-AGCCCT CTTGTTTGATGGC-3'; reverse primer (5' Dnmt1-R), 5'-GCAGGAATTCATGCAGTAAG-3'.
###end p 27
###begin p 28
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c31">31</xref>
###xml 241 244 <span type="species:ncbi:10116">rat</span>
###xml 311 314 <span type="species:ncbi:10116">rat</span>
Oocyte-specific exon 1 is located upstream of somatic exon 1 (Fig. 2A) (31). The amplified 194 bp cDNA was subcloned into pGEM-T easy (Promega) and sequenced. Genomic PCR was then performed by using LA-Taq (TaKaRa), genomic DNA derived from rat kidney and the following primer set designed based on sequence of rat oocyte-specific exon 1: forward primer (5' G-Dnmt1-F), 5'-AGCCCTCTTGTTTG ATGGCCAGGGTGGAGC-3'; reverse primer (3' G-Dnmt1-R), 5'-TCTTGGGGATCGGTTTGAGTCTGCCATTTC-3'.
###end p 28
###begin p 29
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
The amplified 15 kb DNA fragment was digested with EcoRI, subcloned into pBluescript II SK(+) (Stratagene) and sequenced (DDBJ accession no. AB056446).
###end p 29
###begin title 30
Plasmids, transfection and luciferase assay
###end title 30
###begin p 31
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Different lengths of upstream regions of the mouse Dnmt1 gene with either NheI or SmaI and XhoI sites were generated by a PCR-based method. These fragments were subcloned into PGV-B2 luciferase plasmid (Nippon Gene). Primer sets are as follows: 2061-luc sense, 5'-GCCCGGGAGGATTAAAGGT GTGCACCACTACCGCTG-3'; 500-luc sense, 5'-GGCT AGCTCTGGCTTTTGCATTCTGAG-3'; 300-luc sense, 5'-GGCTAGCGAGCCCACTATAGCCAGGAG-3'; 100-luc sense, 5'-GGCTAGCCATGCTGCTTCCGTTGCGCC-3'; common antisense, 5'-GCTCGAGCTTGCAGGTTGCAG ACGACAGAAC-3'; R756-luc sense, 5'-GCTCGAGCA CTGCGCAGACAAGCCCAC-3'; R756 antisense, 5'-GGCTAGCCTTGCAGGTTGCAGACGACA-3'.
###end p 31
###begin p 32
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 406 408 406 408 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AT</underline>
###xml 450 452 450 452 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AT</underline>
###xml 502 504 502 504 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AT</underline>
###xml 545 547 545 547 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AT</underline>
###xml 595 597 595 597 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AT</underline>
###xml 641 643 641 643 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AT</underline>
###xml 691 693 691 693 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AT</underline>
###xml 735 737 735 737 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AT</underline>
736-luc was generated by insertion of a NheI-XhoI fragment digested from the p2061 luciferase plasmid into the PGV-B2 luciferase plasmid. Point mutations were generated with the QuikChange Site-directed Mutagenesis Kit (Stratagene) as specified in the manufacturer's instructions. Oligonucleotide sets used for the mutagenesis were as follows (mutated nucleotides are underlined): site A, 5'-GTGCCT CCGTTGCATGCATGCGCACTCCCTTC-3' and 5'-GAA GGGAGTGCGCATGCATGCAACGGAGGCAC-3'; site B, 5'-CATGCGCACTCCCTTCGATCATAGCATGGTCTTC-3' and 5'-GAAGACCATGCTATGATCGAAGGGAGTGCG CATG-3'; site C, 5'-CTGCTTCCGCTTGCATCGCCCCCT CCCAATTG-3' and 5'-CAATTGGGAGGGGGCGATGC AAGCGGAAGCAG-3'; site D, 5'-CTCCCAATTGGT TTCCATGCGCGCGAAAAAGCC-3' and 5'-GGCTTTTTC GCGCGCATGGAAACCAATTGGGAG-3'.
###end p 32
###begin p 33
Further mutagenesis was carried out using the mutated luciferase plasmids as templates and the oligonucleotide sets described above. All clones were verified by sequencing.
###end p 33
###begin p 34
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 189 196 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 289 291 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c30">30</xref>
###xml 585 592 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 835 837 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c32">32</xref>
###xml 220 224 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 538 543 <span type="species:ncbi:10090">mouse</span>
###xml 616 620 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
For the luciferase assay, 2 x 104 COS-7 cells were seeded in a 24-well plate and cultured overnight. The cells were co-transfected with 0.95 microg of luciferase plasmid and 0.05 microg of Renilla luciferase plasmid pRL-SV40 as an internal control by using a standard DEAE-dextran method (30). Alternatively, NIH 3T3 cells, cultured as above, were co-transfected with a total of 0.2 microg plasmids, which consisted of various luciferase plasmids and expression vector plasmids (pDCE2F1, a kind gift from Dr K. Ohtani, and pME18S SRalpha mouse Rb, a kind gift from Dr T. Yamamoto) and Renilla luciferase plasmid pRL-SV40 as an internal control. The Lipofectamine PLUS transfection method (Gibco BRL) was used as specified by the manufacturer's instructions. TSA (a kind gift from Dr M. Yoshida) was added 24 h before harvesting cells (32). The cells were harvested 48 h after transfection, lysed and the degree of transactivation was measured with a PicaGene Dual SeaPansy Luminescence Kit (Nippon Gene) as specified by the manufacturer's instructions. All assays were repeated at least twice with triplicate determinants.
###end p 34
###begin title 35
Electrophoretic mobility shift assay (EMSA)
###end title 35
###begin p 36
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 309 310 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 312 313 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 578 579 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 748 749 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 854 856 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
NIH 3T3 cells were washed twice with ice-cold PBS and scraped into microcentrifuge tubes. Cells were pelleted by centrifugation at 2300 g at 4degreesC and then pipetted up and down 10 times in 10 vol of lysis buffer [50 mM HEPES, pH 7.9, 250 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.1% NP-40, 0.4 mM NaF, 0.4 mM Na3VO4, 10% glycerol, 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 2 microg/ml aprotinin, 1 microg/ml pepstatin, 2 microg/ml leupeptin] and were incubated on ice for 30 min. Cleared whole cell extracts were obtained by centrifugation at 20 000 g at 4degreesC for 30 min. DNA binding assays contained 10 microg of total protein in 10 microl of DNA binding reaction mixture (20 mM HEPES, pH 7.9, 40 mM KCl, 6 mM MgCl2, 1 mM DTT, 1 mM PMSF, 0.1% NP-40, 10% glycerol, 50 microg/ml sonicated salmon sperm DNA) and 0.14 ng of 32P-labeled DNA probe. DNA probes were as follows: E2F oligonucleotide, 5'-TCCGTTTTCGCGCTTAAATTTGAGAAAGGGCGCGAAACTGGA-3'; probe A, 5'-GTGCCTCCGTTGCGCGCA TGCGCAC-3'; probe C, 5'-CCAATTGGTTTCCGCGCGC GCGAAAAAGCCGGGGTCTCGTTC-3'.
###end p 36
###begin p 37
###xml 360 361 354 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The reaction mixtures were incubated at room temperature for 20 min and resolved by electrophoresis on a 5% polyacrylamide gel (acrylamide/bis 80:1) in 0.25x TBEG (12.5 mM Tris-borate, 0.25 mM EGTA) containing 5% glycerol at 4degreesC. Alternative DNA binding assays were carried out with DNA binding reaction mixture [10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM MgCl2, 0.5 mM EDTA, 50 microg/ml poly(dI-dC).(dI-dC), 4% glycerol] in TBE (50 mM Tris-borate, 1 mM EDTA) at 4degreesC.
###end p 37
###begin title 38
Western blot analysis
###end title 38
###begin p 39
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 269 270 263 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 272 273 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 467 468 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 681 683 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c33">33</xref>
###xml 694 698 674 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Waf1</sup>
NIH 3T3 cells were harvested and washed three times with ice-cold PBS. The cells were pelleted by centrifugation at 2300 g at 4degreesC. NP-40 lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 10% glycerol, 1 mM DTT, 0.5 mM EDTA, 0.5 mM EGTA, 0.5 mM NaF, 1 mM Na3VO4, 1% aprotinin, 5 microg/ml leupeptin, 0.7 microg/ml pepstatin) was added to the cell pellets and placed on ice for 30 min. Cleared whole cell extracts were prepared by centrifugation at 20 000 g for 30 min at 4degreesC. Protein concentration was measured by using a BCA kit (Pierce) according to the manufacturer's instructions. Whole cell extracts were subjected to western blot analysis using anti-Dnmt1 (33), anti-p21Waf1 (Santa Cruz) and anti-beta-tubulin (Sigma) antibodies.
###end p 39
###begin title 40
RESULTS
###end title 40
###begin title 41
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Dnmt1 mRNA increases at late G1/early S phase
###end title 41
###begin p 42
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 128 137 128 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f1">1</xref>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 368 377 368 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 445 453 445 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
To investigate the cell cycle-dependent Dnmt1 transcription, we examined the expression of three genes in NIH 3T3 cells; Dnmt1, cyclin D1 and cyclin E (Fig. 1A). Analysis of RNA from quiescent and serum-stimulated cells revealed a strong induction of each gene. Dnmt1 transcript started to accumulate at 9 h after serum stimulation and reached maximum levels at 20 h. cyclin D1 mRNA began to accumulate at 6 h and reached maximum levels at 9 h. cyclin E transcript was elevated at 9 h and peaked at 12 h.
###end p 42
###begin p 43
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f1">1</xref>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 478 487 478 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
###xml 595 600 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 605 614 605 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 684 692 684 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
###xml 743 752 743 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 790 791 790 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 805 810 805 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 848 849 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 917 922 917 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 946 947 946 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
To examine the cell cycle distribution of the cells after serum stimulation, we measured DNA content (Fig. 1B). Nine hours after addition of serum, about 7% of cells had entered S phase, whereas after 12 h, 23% of cells had entered S phase. After 16 h, 74% of cells had progressed into S phase, and then passed through S phase at 20 h. Similar results on FACScan analysis were obtained from two independent experiments. At 0 h, the quiescent cells had very low levels of Dnmt1, cyclin D1 and cyclin E mRNA, but expression of all three genes increased 20- to 30-fold following serum stimulation. Dnmt1 and cyclin D1 mRNA remained constant following their initial accumulation, whereas cyclin E mRNA declined as cells proceeded through S phase. cyclin D1 mRNA started to accumulate from mid-G1 phase, while Dnmt1 RNA started to accumulate from late G1 to early S phase. These results indicate that the transcription of Dnmt1 was activated at late G1 in our system.
###end p 43
###begin p 44
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f1">1</xref>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-fos</italic>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c18">18</xref>
###xml 78 81 <span type="species:ncbi:10116">rat</span>
###xml 100 103 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
###xml 197 201 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To examine Dnmt1 expression in transformed cells, total RNA was prepared from rat-derived 3Y1 (WT), RSV-transformed 3Y1 (SR-3Y1), Ha-ras-transformed 3Y1 (HR-3Y1), E1A-transformed 3Y1 (E1A-3Y1) and SV40-transformed 3Y1 cells (SV-3Y1 cells). The transformed cells had approximately 2- to 3-fold more Dnmt1 mRNA than the parental wild-type cells (Fig. 1C), suggesting that a modest increase in Dnmt1 mRNA is associated with cell transformation. Our observations are consistent with the levels of Dnmt1 expression observed in cells transformed by c-fos (18).
###end p 44
###begin title 45
Genomic cloning of the 5' upstream region and identification of the transcription start sites of Dnmt1
###end title 45
###begin p 46
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c31">31</xref>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
To identify the promoter of the mouse Dnmt1 gene, we isolated and sequenced a 9.6 kb fragment containing a complete somatic exon 1 (31) and 8.5 kb upstream from the translation start codon. The 2061 bases immediately upstream from the translation start codon did not contain a TATAA sequence (DDBJ accession no. AB056445).
###end p 46
###begin p 47
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c31">31</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c34">34</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c35">35</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
###xml 876 877 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
###xml 1269 1274 1257 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1296 1301 1284 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1394 1399 1382 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1406 1407 1394 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
Dnmt1 codes for three distinct gene products, the somatic form, the oocyte-specific form and the testis-specific form (31). Sequencing showed a possible transcription initiator sequence (Inr) (5'-CCACTCT-3', PyPyANT/APyPy) (34,35) located at bases -123 to -117 upstream of the translation start codon (Fig. 2A). To confirm this experimentally, RNase protection assays were performed using RNA from NIH 3T3 cells. Probes used were an 80 base fragment directly downstream from the ATG in somatic exon 1 (probe 80) and a 380 base fragment spanning from 300 bases upstream of the ATG to 80 bases downstream of the ATG (probe 380) (Fig. 2B). Probe 80 is a positive control for the molecular weight of hybridized RNAs. As expected, probe 80 detected an 80 bp fragment of somatic exon 1 (arrowhead in Fig. 2C). Probe 380 produced a major signal at approximately190 bp (arrow in Fig. 2C). This result shows that transcription is initiated around 110 bases upstream from the translation start codon ATG. To further confirm the transcription start sites, northern blot analysis was performed using two probes, one of which hybridizes 610 bases upstream from the initiator sequence (probe 1) and the other (probe 2) corresponding to the catalytic domain in the coding sequence of Dnmt1. Probe 1 detected no Dnmt1 mRNA, whereas probe 2 detected a 5.2 kb band, which is the major transcript size of somatic Dnmt1 (Fig. 2D). These data indicate that the major transcription start sites are between -123 and -117.
###end p 47
###begin title 48
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
Two major cis-elements in the core promoter of Dnmt1
###end title 48
###begin p 49
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 891 896 891 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1152 1157 1152 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
To identify the promoter region essential for transcriptional regulation of Dnmt1 during cell proliferation, we transfected COS-7 cells with luciferase reporter constructs containing deletions of the Dnmt1 5'-flanking region. The luciferase activity from plasmids containing 2061, 736, 500 or 300 bp upstream of the translation start codon of Dnmt1 was 25- to 40-fold higher than that of a control plasmid without insert (Fig. 3A). However, the luciferase activity of a plasmid containing 100 bp of 5' sequence of Dnmt1 was similar to control levels. To confirm that the promoter activity of the upstream sequence was unidirectional, we constructed a luciferase reporter plasmid containing 736 bp of upstream sequence in the reverse orientation (R736). The luciferase activity of R736 was comparable to the control levels. These data indicate that the 300 bases of the 5' flanking region of Dnmt1 is a core promoter sequence. Additionally, we examined the 1.5 kb region upstream from the oocyte-specific ATG codon using luciferase assays. No luciferase activity was detected in COS-7 cells (data not shown), suggesting that the oocyte-specific form of Dnmt1 may be regulated by an oocyte-specific regulatory mechanism.
###end p 49
###begin p 50
###xml 19 20 19 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f1">1</xref>
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 675 676 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 854 855 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 987 988 975 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 1145 1150 1133 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
As shown in Figure 1, Dnmt1 is expressed in a cell cycle-dependent manner. The core promoter region of Dnmt1 contained four putative E2F binding sites (sites A-D, Fig. 2A). To test the possibility that transcription of Dnmt1 may also be regulated by E2F transcription factors, we analyzed the luciferase activity of the core promoter sequence of Dnmt1 by creating point mutations in the putative E2F binding sites. Relative to wild-type sequence (Fig. 3B, column 1), point mutations at either site A or site C decreased the promoter activity by 40-50% (Fig. 3B, columns 2 and 4). However, mutation in either site B or site D reduced the promoter activity only slightly (Fig. 3B, columns 3 and 5). The combination of several point mutations showed that mutations of both site A and site C further decreased the promoter activity by approximately60% (Fig. 3B, columns 7, 8 and 10). Other plasmids containing mutations in either site A or site C produced 60% of the promoter activity (Fig. 3B, columns 6 and 9). These findings showed that the putative E2F binding site A and site C in the core promoter play a significant role in the activation of Dnmt1 transcription.
###end p 50
###begin p 51
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
To confirm that these decreases in the promoter activity of Dnmt1 are not specific to COS-7 cells, we also analyzed Dnmt1 promoter activity of site A and site C in NIH 3T3 cells (Fig. 3C). The decrease in promoter activity in NIH 3T3 cells was similar to that observed in COS-7 cells, indicating that these two cis-elements are crucial for the transcriptional regulation of Dnmt1 in proliferating cells.
###end p 51
###begin title 52
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
Dnmt1 core promoter activity in oncogenic transformed cells
###end title 52
###begin p 53
###xml 19 20 19 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f1">1</xref>
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f4">4</xref>
As shown in Figure 1C, Dnmt1 mRNA increased approximately 2-fold in transformed cells. To examine whether this accumulation of Dnmt1 mRNA reflects altered promoter activity, we transfected the luciferase reporter construct containing the Dnmt1 core promoter (300-luc in Fig. 3A) into transformed 3Y1 cells. All transformed cells showed at least 30 times more transctiptional activity than parental 3Y1 cells (Fig. 4A), indicating that the promoter activity is increased in the transformed cells.
###end p 53
###begin p 54
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c24">24</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c24">24</xref>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f4">4</xref>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f4">4</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f4">4</xref>
###xml 847 852 847 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 959 964 959 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1309 1314 1309 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1321 1322 1321 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f4">4</xref>
###xml 173 177 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 504 508 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 887 891 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1295 1300 <span type="species:ncbi:10090">mouse</span>
###xml 1305 1308 <span type="species:ncbi:10116">rat</span>
E2F trans-activity is inactivated by binding to Rb, but it is activated by releasing Rb on phosphorylation of Rb by Rb kinases (24). The Rb-E2F complex is also disrupted by SV40 large T antigen or expression of a pocket domain mutant form of Rb which cannot bind to E2F (24). To determine whether up-regulation of Dnmt1 mRNA is dependent on E2F binding to site A and site C in the promoter, we measured luciferase activity of mutated Dnmt1 core promoters in SV-3Y1 cells which have been transformed with SV40 (Fig. 4B). In SV-3Y1 cells, the wild-type Dnmt1 promoter had 30-fold greater promoter activity than parental 3Y1 cells (Fig. 4A). The constructs containing mutations in site A (300A), site C (300C) or in both (300AC) showed lower promoter activity than the wild-type construct (300) in SV-3Y1 cells (Fig. 4B). These results indicate that Dnmt1 transcription may be activated by SV40 large T antigen through sites A and C. Therefore, transcription of Dnmt1 is likely activated by E2F transcription factors binding to sites A and C in the promoter, and both putative E2F binding sites A and C are required to enhance promoter activity in SV-3Y1 cells. These observations are unlikely to result from differences between species, because the core promoter region is highly conserved across mouse and rat Dnmt1 (Fig. 4C).
###end p 54
###begin p 55
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 243 246 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 412 415 412 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 92 95 <span type="species:ncbi:10116">rat</span>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
###xml 150 153 <span type="species:ncbi:10116">rat</span>
Interestingly, the sequence of site C in mouse Dnmt1 matches exactly with that of site C in rat, but the sequence of site A differs between mouse and rat. Taken together, our findings suggest that Dnmt1 transcription is controlled through two cis-elements in both normal and transformed cells. It is possible, however, that factors other than E2F are responsible for activation of Dnmt1 expression through these cis-elements.
###end p 55
###begin title 56
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
Two distinct transcription factors bind to two cis-elements
###end title 56
###begin p 57
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f4">4</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c36">36</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 1056 1057 1056 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 1138 1139 1138 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 1387 1388 1387 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 1527 1528 1527 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 1817 1819 1817 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c37">37</xref>
###xml 1972 1973 1972 1973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 2062 2064 2062 2064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c37">37</xref>
###xml 2303 2304 2303 2304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 2336 2337 2336 2337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f5">5</xref>
###xml 2390 2395 2390 2395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
To examine whether E2F binds to sites A and C in the promoter of Dnmt1, we performed EMSA using oligonucleotides corresponding to site A or site C (Fig. 4C, probes A and C) and to the E2F consensus binding sequence (36). Binding activity to probe A was detectable (Fig. 5A, lane 2), and the DNA-protein complexes disappeared when unlabeled probe A was used as a competitor (Fig. 5A, lane 3). However, binding was present when the sequence of site A was mutated in the competitor (Fig. 5A, lane 6), consistent with the luciferase assays using the point mutated constructs shown in Figure 3. Moreover, neither the E2F consensus oligonucleotide nor the site C oligonucleotide was able to compete against probe A (Fig. 5B, lanes 4 and 5), indicating that E2F does not bind site A. To confirm this, we repeated EMSA under another condition in which poly(dI-dC) was used as a blocking reagent. In this condition, the major shifted band was competed off by probe A but not by mutated probe A, E2F consensus oligonucleotide or Sp-1 consensus oligonucleotide (Fig. 5, lanes 3-6). EMSA with mutant probe A showed no detectable specific shift (Fig. 5B, lane 7), findings that indicate that a transcription factor other than E2F binds to site A. To examine this further, we analyzed whole cell extracts from NIH 3T3 cells by EMSA, using the site A and E2F consensus oligonucleotides as probes (Fig. 5C). The mobility shift of the DNA-protein complexes using site A differed from that of those using the E2F consensus oligonucleotide (Fig. 5C, lanes 1 and 2). These results indicate that E2F transcription factors are unable to bind to site A. The oligonucleotides corresponding to site A differ from the Sp-1 consensus sequence (G/T)GGGCGGG(GGC/AAT) and Sp-1/3 consensus sequence (GGCAAGGGGGAGGTG), which lie upstream of site A (37), and also from the AP-1 consensus sequence TGACTCA. As expected, the protein bound to site A was not competed off by the Sp-1 consensus sequence (Fig. 5B, lane 6). EMSA using the Sp-1/3 binding element previously detected three major bands (37). Therefore, our data indicate that the protein bound to site A is a factor other than E2F, Sp-1 or AP-1. On the other hand, site C oligonucleotide specifically inhibited formation of E2F consensus oligonucleotide-protein complexes (Fig. 5C, lane 4) and vice versa (Fig. 5D, lane 4). These data collectively suggest that the Dnmt1 promoter may be activated by both E2F at site C and another unidentified transcription factor at site A.
###end p 57
###begin title 58
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
E2F-1 activates the Dnmt1 promoter
###end title 58
###begin p 59
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c24">24</xref>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c38">38</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c27">27</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c39">39</xref>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c17">17</xref>
###xml 562 567 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 941 942 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 1037 1038 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 1098 1103 1098 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1284 1285 1284 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 1324 1329 1324 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 556 561 <span type="species:ncbi:10090">mouse</span>
The family of E2F transcription factors consists of E2F-1, E2F-2, E2F-3, E2F-4 and E2F-5, all of which possess DNA binding activity, and E2F-6, which does not have a transcriptional activation domain (24). Individual E2F members recognize specific binding sequences of target genes in vivo (38). E2F-1 possesses both oncogenic and tumor suppressor properties (27,39). Ectopic expression of Dnmt1 in NIH 3T3 cells causes cellular transformation and tumorigenesis (17). Considering these observations and the apparent E2F binding properties of site C in the mouse Dnmt1 promoter, Dnmt1 is potentially a target gene of E2F-1. To examine this, we co-transfected the core promoter reporter plasmids along with an E2F-1 expression vector into NIH 3T3 cells (Fig. 6A). With the wild-type promoter, co-transfected E2F-1 increased the promoter activity (Fig. 6A, column 2). The mutation in site C decreased luciferase activity of E2F-1 by half (Fig. 6A, column 4), whereas the mutation in site A decreased luciferase activity only slightly (Fig. 6A, column 3). These results indicate that activation of the Dnmt1 core promoter by E2F-1 depends upon site C but not site A. Remarkably, double mutation at sites A and C reduced the promoter activity further than the site C single mutation (Fig. 6A, column 5). These data indicate that Dnmt1 is activated by E2F-1 mainly through site C; however, a molecule bound to site A works cooperatively with E2F-dependent transcriptional activity.
###end p 59
###begin title 60
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
Distinct roles of two cis-elements during the cell cycle
###end title 60
###begin p 61
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 369 370 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 372 373 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 394 395 394 395 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f1">1</xref>
To examine which cis-element contributes to the regulation of transcriptional activity of Dnmt1 during the cell cycle, we transfected NIH 3T3 cells with luciferase reporter plasmids containing the wild-type Dnmt1 core promoter or the promoter containing point mutations in site A and site C. Luciferase activities were measured in quiescent cells by serum starvation (G0/G1 phase) and 9 (late-G1 phase), 12 (G1/S phase) and 16 h (S phase) after serum stimulation of these cells (Fig. 6B, cf. Fig. 1B). Overall, plasmids in which site C remained intact showed cell cycle-dependent variation in luciferase activity, whereas plasmids with mutated site C showed far less variation.
###end p 61
###begin p 62
###xml 4 5 4 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 7 8 7 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c9">9</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c40">40</xref>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 560 561 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 563 564 563 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
In G0/G1 phase, luciferase activity was detectable, illustrating that the Dnmt1 promoter had basal Dnmt1 promoter activity in resting cells (Fig. 6B, column 1), consistent with previous reports (9,40). The plasmids with mutated site A had decreased luciferase activity whereas those with mutated site C showed increased activity (Fig. 6B, columns 2 and 3). These results suggest that transcriptional activity of Dnmt1 is repressed by the binding of E2F-Rb complex to site C, and that a nuclear factor which activates Dnmt1 expression through site A exists in G0/G1 phase cells.
###end p 62
###begin p 63
###xml 9 10 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 142 143 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 329 330 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 345 346 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 389 390 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
In late G1 phase, transcriptional activity was repressed through the E2F binding site (site C) (Fig. 6B, compare columns 6 and 8). Unlike in G0/G1 phase cells, the plasmid with mutated site A showed no decrease in luciferase activity (Fig. 6B, columns 2 and 7). The site A-binding nuclear factors may act differently between G0/G1 and mid/late-G1 phase. Dnmt1 promoter activity peaked in G1/S phase (Fig. 6B, column 11), and declined slightly at S phase (Fig. 6B, column 16).
###end p 63
###begin p 64
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f6">6</xref>
###xml 322 325 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
Promoter activity of reporter plasmids with the mutation at site C did not vary during the cell cycle (Fig. 6B, columns 3, 8, 13 and 18), whereas in each phase transcription from the double mutant plasmids was lower than transcription in the wild type (Fig. 6B, columns 4, 9, 14 and 19). These data suggest that these two cis-elements play distinct and important roles in the regulation of Dnmt1 expression. During the cell cycle, basal transcriptional levels of Dnmt1 appear to be maintained through site A while site C (E2F site) modulates Dnmt1 transcriptional levels both positively and negatively in a cell cycle-specific manner.
###end p 64
###begin title 65
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
TSA activates the Dnmt1 promoter
###end title 65
###begin p 66
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c25">25</xref>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 329 332 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Waf1</italic>
###xml 332 336 332 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Waf1</italic></sup>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c41">41</xref>
###xml 383 384 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 389 390 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c42">42</xref>
###xml 434 438 434 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Waf1</sup>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
Since it has been shown that E2F-Rb complexes can repress transcription by recruiting HDAC (25), we examined expression of Dnmt1 in proliferating NIH 3T3 cells after treatment with TSA, a HDAC-specific inhibitor. The amount of Dnmt1 mRNA was reduced in TSA-treated cells (Fig. 7A). TSA can also activate the promoter activity of p21Waf1, a cdk inhibitor (41) which arrests cells at G1 or G2 phase (42). We confirmed an increase in p21Waf1 protein level that occurs in a dose-dependent manner in response to TSA treatment (Fig. 7B). Dnmt1 protein level at 50 nM TSA was decreased, in agreement with measured mRNA levels.
###end p 66
###begin p 67
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 189 190 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 238 239 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
To investigate the cell cycle distribution of cells after addition of TSA, we measured the DNA content by FACScan analysis (Fig. 7C). A low dose of TSA (50 nM) arrested the cells in G1 or G2 phase, confirming that Dnmt1 mRNA declined in G1 and G2 phases. However, the S phase distribution of the cells treated with higher doses of TSA increased slightly (Fig. 7C), and Dnmt1 mRNA levels in TSA-treated cells appeared to increase in a TSA dose-dependent fashion (Fig. 7A).
###end p 67
###begin p 68
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c43">43</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c44">44</xref>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 228 229 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 384 385 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 387 388 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 892 893 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 1015 1016 1015 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 1308 1309 1308 1309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 1311 1312 1311 1312 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1334 1335 1334 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 1359 1360 1359 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 1470 1471 1470 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f7">7</xref>
###xml 1521 1526 1521 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 81 88 <span type="species:ncbi:8355">Xenopus</span>
It is known that supercoiled plasmid DNA introduced into mammalian cell lines or Xenopus oocytes forms nucleosome-containing minichromosomes in the nucleus after 16 h (43,44). We examined Dnmt1 promoter activity in cells at G0/G1 phase by luciferase assay to see if there is any HDAC-dependent repression. NIH 3T3 cells transfected with luciferase reporter plasmids were arrested at G0/G1 and treated with 200 nM TSA for 24 h. In all cases, the luciferase activity was higher in TSA-treated cells than in untreated cells (Fig. 7D). The luciferase activity of plasmids with a mutation in site A increased to a greater extent than that of the control plasmids (Fig. 7D, columns 6 and 7), implying that the binding of E2F to site C resulted in the formation of E2F-Rb-HDAC complex. When 200 nM TSA was added to serum-starved NIH 3T3 cells, the distribution of the cell cycle was unchanged (Fig. 7E). The luciferase activity of the plasmids with the mutated E2F site (site C) increased 3-fold after TSA treatment (Fig. 7D, columns 3 and 8), suggesting that the site A-binding complex possesses some HDAC activity. The luciferase activity of plasmids with a mutation in site A is dependent upon promoter activity of site C. Plasmid 300A showed a 7-fold increase in luciferase activity following TSA treatment in G0/G1 arrested cells (Fig. 7D, columns 2 and 7, and 7E). As expected, the double mutated promoter activity did not increase significantly when TSA was added (Fig. 7D, columns 4 and 9). These data indicate that the Dnmt1 core promoter is regulated through dual pathways dependent upon sites A and C, and these sites are associated with HDAC activity.
###end p 68
###begin title 69
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
Dnmt1 promoter activity is negatively regulated by E2F-Rb-HDAC
###end title 69
###begin p 70
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c45">45</xref>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f8">8</xref>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f8">8</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f8">8</xref>
###xml 983 984 983 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f8">8</xref>
###xml 1129 1130 1129 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f8">8</xref>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
To investigate whether negative regulation of Dnmt1 promoter activity is associated with the formation of E2F-Rb-HDAC complexes, we co-transfected luciferase reporter plasmids and E2F-1 and Rb expression vectors into Saos-2 osteosarcoma cells which lack functional Rb and express E2F target genes at high levels (45). TSA was added to the cells 24 h after transfection, and the cells were harvested after 24 h in culture (Fig. 8). As expected, the core promoter activity of Dnmt1 when co-transfected with the E2F-1 expression vector increased by 50% (Fig. 8, column 2); however, co-transfection with E2F-1 and Rb expression vectors decreased luciferase activity by 50% as compared to co-transfection with E2F-1 expression vector alone (Fig. 8, columns 2 and 3). These results indicate that the formation of an E2F-1-Rb complex repressed the Dnmt1 core promoter activity. The decrease in luciferase activity caused by Rb expression was reversed by addition of 100 or 200 nM TSA (Fig. 8, columns 4 and 5). We performed luciferase assays with the reporter plasmids containing a mutation in site A and obtained similar results (Fig. 8, columns 6-10). Our data indicate that repression of Dnmt1 core promoter activity by E2F-1-Rb complexes is dependent upon HDAC and occurs through site C. Taken together, these findings show that the Dnmt1 promoter activity is both positively and negatively regulated by E2F complexes.
###end p 70
###begin title 71
DISCUSSION
###end title 71
###begin p 72
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
In the present study, we demonstrate that there are two major cis-elements in the promoter region of mouse Dnmt1 that control transcriptional levels during the cell cycle. Dual regulatory pathways, one involving unknown transcription factors and the other involving E2F-Rb-HDAC, play a pivotal role in cell cycle-dependent regulation of Dnmt1 expression. Both pathways may be necessary for controlling gene expression by methylation; however, further investigation of growth-sensitive methylation checkpoints will be required in both normal cell growth and tumor development.
###end p 72
###begin p 73
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c46">46</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c47">47</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c16">16</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c17">17</xref>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 584 589 584 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 806 811 806 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 934 935 934 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f9">9</xref>
###xml 991 992 991 992 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1038 1039 1038 1039 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 1041 1042 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1121 1122 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f9">9</xref>
###xml 1131 1136 1131 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 557 562 <span type="species:ncbi:10090">mouse</span>
It has been thought that DNA methylation in vivo is maintained by activation of Dnmt1, whereas demethylation is achieved passively by inactivation of Dnmt1. However, over-expression of Dnmt1 has been reported in several cancer cells (46,47), and an intimate relationship between aberrant methylation of genomic DNA and tumorigenesis has been documented (16,17). To clarify how cells produce the appropriate amount of Dnmt1, we investigated the regulation of Dnmt1 expression. First, we identified the promoter region and the major transcript start sites of mouse Dnmt1. Expression of Dnmt1 was regulated through at least two distinct cis-elements (sites A and C). Site C binds E2F and site A binds factors yet to be identified. Our data show that the E2F binding site regulates transcriptional activity of Dnmt1 both positively and negatively in a cell cycle-dependent manner. A model of this complex regulation is proposed in Figure 9. The E2F binding site activates transcription at late G1/S phase and represses it to basal levels at G0/G1 phase by recruiting HDAC through the formation of E2F-Rb-HDAC complexes (Fig. 9). Since Dnmt1 transcription occurs in resting cells, it appears that Dnmt1 functions outside of the cell cycle in quiescent and terminally differentiated cells.
###end p 73
###begin p 74
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-1</italic>
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-2</italic>
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-3</italic>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-4</italic>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-5</italic>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c39">39</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c48">48</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c51">51</xref>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-1</italic>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c39">39</xref>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c33">33</xref>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c52">52</xref>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c53">53</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c52">52</xref>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c53">53</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c52">52</xref>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
Loss of E2F-1, E2F-2, E2F-3, E2F-4 and E2F-5 gene function results in a diversity of phenotypes (39,48-51). In particular, mice lacking E2F-1 develop tumors (39), implying that E2F-1 functions as a tumor suppressor in vivo. Additionally, the Rb-E2F pathway is responsible for control of cell growth (33). Our data suggest that disruption of the E2F-1-Rb-HDAC regulatory complex formed on the Dnmt1 promoter leads to ectopic expression of Dnmt1, potentially contributing to tumor progression. The different patterns of methylation observed in cancer cells suggest that this E2F-Dnmt1 pathway might accelerate aberrant methylation in tumor malignancy. Rb-E2F pathways may be involved in Dnmt1-associated tumorigenesis at multiple levels. Recently, mice have been made with disruptions in Rb family genes, eliminating the possibility for compensation (52,53). Embryonic fibroblasts derived from these mice are immortal and exhibit properties of transformed cells (52,53). Colony formation was completely inhibited by reintroduction of Rb into these cells (52). Considering these results, our findings strongly suggest that disruption of the Rb-E2F-Dnmt1 regulatory pathway may play a critical role in tumorigenesis.
###end p 74
###begin p 75
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c54">54</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c11">11</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c55">55</xref>
###xml 485 488 485 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16</italic>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ink4A</italic>
###xml 488 493 488 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ink4A</italic></sup>
###xml 495 498 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p19</italic>
###xml 498 501 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arf</italic>
###xml 498 501 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Arf</italic></sup>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 509 513 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Waf1</italic>
###xml 509 513 509 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Waf1</italic></sup>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c54">54</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c56">56</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c57">57</xref>
###xml 541 544 541 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Waf1</italic>
###xml 544 548 544 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Waf1</italic></sup>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c57">57</xref>
###xml 879 884 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1142 1143 1142 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c6">6</xref>
###xml 1210 1215 1210 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1240 1241 1240 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c6">6</xref>
###xml 1242 1244 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c18">18</xref>
Robertson et al. have reported that Dnmt1 directly interacts with Rb, thereby reducing transcriptional activity of E2F-responsive genes via histone deacetylation (54). Dnmt1 also interacts directly with E2F-1 and HDAC (11,55), implying that Dnmt1 works not only through maintenance of genome-wide methylation, but also through histone deacetylation. Indeed, recent studies have shown that the inhibition of Dnmt1 results in enhanced promoter activity of tumor suppressor genes such as p16Ink4A, p19Arf and p21Waf1 (54,56,57). In the case of p21Waf1, although its promoter activity is elevated by decreases in Dnmt1, the CpG sequences in the promoter region are completely unmethylated even though Dnmt1 is expressed normally (57). This suggests that Dnmt1 itself may participate in a transcriptional regulatory mechanism in addition to its role in maintenance methylation. Since Dnmt1 is E2F-responsive, Dnmt1 may regulate its own transcription through a negative feedback system, through the formation of complexes such as E2F-Rb-Dnmt1-HDAC. Ectopic expression of Dnmt1 in higher levels than levels in transformed cells leads to cell death (6), while most transformed cells express apporoximately 2-fold more Dnmt1 mRNA than normal cells (6,18). Therefore, Dnmt1 may be required as part of a restrictive regulatory system to continue normal cell growth.
###end p 75
###begin p 76
###xml 253 257 253 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Waf1</sup>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c12">12</xref>
###xml 315 319 315 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Waf1</sup>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c54">54</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c12">12</xref>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c56">56</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c58">58</xref>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c6">6</xref>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S/+</italic>
###xml 720 723 720 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>S/+</italic></sup>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c19">19</xref>
###xml 927 932 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 932 935 932 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N/+</italic>
###xml 932 935 932 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>N/+</italic></sup>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c59">59</xref>
###xml 1035 1040 1035 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1040 1043 1040 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N/N</italic>
###xml 1040 1043 1040 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>N/N</italic></sup>
###xml 1207 1209 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c60">60</xref>
###xml 151 155 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 724 728 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
Inappropriate levels of Dnmt1 may trigger tumor initiation or progression at multiple steps by disturbing tightly regulated molecular interactions. In SV40-transformed cells, increased levels of Dnmt1 interfere with the molecular interaction between p21Waf1 and PCNA (12), because the binding domain of PCNA for p21Waf1 is the same as that for Dnmt1. Thus, increased Dnmt1 may enhance tumor progression by inappropriate interaction with cell cycle- or DNA repair-related molecules such as Rb (54) and PCNA (12). Importantly, down-regulation of Dnmt1 decreases or arrests cell growth (56,58). Dnmt1-deficient ES cells grow normally, but they die when induced to differentiate (6). Furthermore, Min mice crossed with Dnmt1S/+ mice, which completely lack Dnmt1 activity on one allele, showed 50% fewer intestinal adenomas without large-scale demethylation of genomic DNA (19). A recent study has reported that Min mice crossed to Dnmt1N/+ mice, which partially retain Dnmt1 activity on one allele, also show fewer polyps (59). The mutant Dnmt1N/N ES cells have slightly reduced levels of Dnmt1 enzymatic activity relative to the parental ES cells, yet they retain nearly normal genomic CpG methylation levels (60). Although both monoallelic expression of Dnmt1 and slightly reduced levels of Dnmt1 activity seem to be sufficient for the maintenance of genome-wide methylation and cell viability, these subtle differences affect tumor development significantly. These reports strongly suggest that maintenance of absolute levels of Dnmt1 is critical for both normal and abnormal cell growth. Both methyltransferase activity of Dnmt1 and its ability to interact with other molecules may play important roles in cell proliferation.
###end p 76
###begin p 77
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f9">9</xref>
###xml 478 479 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c9">9</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c29">29</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c40">40</xref>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f4">4</xref>
###xml 950 955 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
###xml 625 628 <span type="species:ncbi:10116">rat</span>
###xml 656 659 <span type="species:ncbi:10116">rat</span>
###xml 667 672 <span type="species:ncbi:10090">mouse</span>
Although site A of Dnmt1 resembles a putative E2F binding sequence, the molecule bound to site A appears to be quite different from E2F transcription factors. Site A mainly functions as a positive regulator of Dnmt1 during the cell cycle. The coordination of the two regulatory sites controls basal and functional activation of the Dnmt1 promoter in proliferating cells (Fig. 9). The transcriptional activity mediated by site A can explain the constant transcriptional rate in G0 phase cells and differentiated cells, compared to proliferating cells (9,29,40). The sequence of the mouse site A is not completely conserved in rat, but proteins derived from rat act on mouse site A (Fig. 4A and B). These findings indicate that the molecule bound to site A recognizes a longer sequence motif than the putative E2F binding site. Further study is required to identify the molecule that binds site A, and to understand the complex molecular mechanisms of Dnmt1 expression regulation in cell growth.
###end p 77
###begin title 78
Figures and Tables
###end title 78
###begin p 79
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 85 86 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 131 140 131 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 145 153 145 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin E</italic>
###xml 325 326 325 326 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 577 578 577 578 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 616 621 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gapdh</italic>
###xml 273 279 <span type="species:ncbi:9913">bovine</span>
###xml 711 714 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
###xml 804 808 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 Expression of Dnmt1 mRNA during the cell cycle and in oncogenic transformed cells. (A) Northern blot showing expression of Dnmt1, cyclin D1 and cyclin E during the cell cycle. Quiescent NIH 3T3 cells were stimulated by replacement with complete medium including 10% fetal bovine serum and harvested at the indicated times. (B) Percentage of cells in each stage of the cell cycle at various times after serum stimulation. DNA amounts were measured by propidium iodide (PI) staining and FACScan analysis. The cell cycle distribution is indicated on the right of the histogram. (C) Northern blot showing expression of Dnmt1 in transformed 3Y1 cells, with gapdh as an internal control. WT, parental 3Y1 cells; SR, RSV-transformed 3Y1 cells; HR, Ha-ras transformed 3Y1 cells; E1A, E1A-transformed cells; SV, SV40-transformed 3Y1 cells.
###end p 79
###begin p 80
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c34">34</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c35">35</xref>
###xml 446 447 446 447 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 489 490 489 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 825 826 825 826 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 905 910 905 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1085 1087 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg406c33">33</xref>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 899 904 <span type="species:ncbi:10090">mouse</span>
 Identification of the transcription start sites of mouse Dnmt1. (A) Nucleotide sequence of the 5'-flanking region and the transcription start site of the mouse Dnmt1 showing the 299 bases upstream from the translation start codon. Boxes A-D indicate putative E2F binding sites. The transcription start site is indicated with an arrow. Exon 1o, oocyte-specific first exon; Exon 1s, somatic first exon; Inr, initiator consensus sequence (34,35). (B) Probes used in RNase protection assay. (C) RNase protection assay. RNA was prepared from NIH 3T3 cells. The major 190 base fragment protected by probe 380 is indicated with an arrow. RMW, size standards with sizes (base pair) corrected for the slower migration of double-stranded RNA based on the migration of the 80 bp double-stranded RNA protected by probe 80 (arrowhead). (D) Northern blot analysis confirmed the transcription of the 5' region of mouse Dnmt1. Total RNA from NIH 3T3 cells was hybridized to probe 1, located 610 bases upstream from the initiator sequence, or probe 2, which corresponds to the Dnmt1 catalytic domain (33).
###end p 80
###begin p 81
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 533 534 533 534 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 836 837 836 837 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
 Identification of the core promoter region of mouse Dnmt1 and two critical binding sites. (A) COS-7 cells were transfected with several promoter fragments linked to a luciferase reporter construct. Results are shown as relative luciferase activity after 48 h. Bars indicate standard deviations (SD). COS-7 cells were transfected with serial deletion constructs of the upstream region: 2061-luc, 736-luc, 500-luc, 300-luc, 100-luc, R736-luc (the 736 bp upstream region in reverse orientation) and No insert-luc (PGV-B2) constructs. (B) COS-7 cells were transiently transfected with constructs containing the first 300 bases upstream of the start codon either with wild-type or mutated (crosses) putative E2F binding sites, or with No insert-luc (PGV-B2). Luciferase activity of the wild-type 300-luc (column 1) was defined to be 100%. (C) As in (B), except that NIH 3T3 cells were used instead of COS-7 cells.
###end p 81
###begin p 82
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 370 371 370 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 656 657 656 657 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f2">2</xref>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
###xml 248 251 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
###xml 341 345 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 715 720 <span type="species:ncbi:10090">mouse</span>
###xml 725 728 <span type="species:ncbi:10116">rat</span>
 Promoter activity of the core promoter region of mouse Dnmt1 in transformed 3Y1 cells. (A) Several cell lines were transiently transfected with the 300-luc construct and luciferase activity was measured as in Figure 3. WT, parental 3Y1 cells; SR, RSV-transformed 3Y1 cells; HR, Ha-ras transformed 3Y1 cells; E1A, E1A-transformed cells; SV, SV40-transformed 3Y1 cells. (B) SV-3Y1 cells were transfected with the 300-luc construct, a construct with mutated site A (300 A), a construct with mutated site C (300 C) or a construct in which both sites A and C were mutated (300 AC). Numbers shown are fold induction relative to luciferase activity of 300-luc. (C) Comparison of the core promoter region of Dnmt1 between mouse and rat. Inr, initiator sequence: sites A and C correspond to those shown in Figure 2A.
###end p 82
###begin p 83
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 187 189 183 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 536 537 532 533 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 840 841 832 833 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 986 987 978 979 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1010 1012 1002 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
 EMSAs to identify molecules bound to site A and site C in the core promoter region of mouse Dnmt1. (A) Complex formation of 10 microg of whole cell extracts (WCE) from NIH 3T3 cells and 32P-labeled site A oligonucleotides (probe A) analyzed under E2F gel shift conditions. Excess unlabeled oligonucleotides (1:150 molar) were used as competitors; A, site A oligonucleotide; E2F, E2F binding site consensus oligonucleotide; C, site C oligonucleotide; mA, mutated site A oligonucleotide. An arrow indicates the probe A-protein complex. (B) Complex formation as above analyzed under alternative gel shift conditions (see Materials and Methods) with 8 microg of WCE. Excess unlabeled oligonucleotides (1:75 molar) were used as competitors; Sp, Sp-1 consensus oligonucleotide; others as in (A). An arrow indicates the probe A-protein complex. (C) Different patterns of mobility shift in sites A and C. The assays were carried out as in (A). An arrow indicates the probe A-protein complex. (D) Complex formation on 32P-labeled site C oligonucleotides. Conditions and competitors are the same as in (A). The upper bracket indicates probe C-protein complexes, representative of E2F bound to site C.
###end p 83
###begin p 84
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg406f3">3</xref>
###xml 757 758 757 758 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 1351 1358 1351 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
 Promoter activity of two cis-elements enhanced by E2F-1 during the cell cycle. (A) Effect of E2F-1 on the activity of the Dnmt1 core promoter region in NIH 3T3 cells co-transfected with the E2F-1 expression vector pDCE2F-1 and the Dnmt1 promoter constructs. NIH 3T3 cells were co-transfected with either the 300-luc construct (300), the construct with mutated site A (300 A), the construct with mutated site C (300 C) or a construct with mutated sites A and C (300 AC). The ratio of luciferase reporter plasmid, E2F-1 expression vector and pRL-SV internal control vector is 10:10:1. Luciferase activity was determined as described in Figure 3A. Numbers shown are fold induction relative to luciferase activity of 300-luc in wild-type, parental 3Y1 cells. (B) Activity of intact and mutated Dnmt1 promoters at various stages in the cell cycle. NIH 3T3 cells were transfected with the 300-luc (columns 1, 6, 11 and 16), 300 A-luc (columns 2, 7, 12 and 17), 300 C-luc (columns 3, 8, 13 and 18), 300 AC-luc (columns 4, 9, 14 and 19) and No insert-luc (columns 5, 10, 15 and 20). After 24 h, the cells were arrested by serum starvation, and 36 h later were stimulated by replacement with complete medium. The cells were harvested at the indicated times after serum stimulation for luciferase activity analysis. The luciferase activities are normalized to Renilla luciferase activity. Numbers indicated are luciferase activity relative to the No insert-luc at each time point.
###end p 84
###begin p 85
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 223 224 223 224 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 403 404 403 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 548 549 548 549 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 619 620 619 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 622 623 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1050 1057 1050 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 1152 1153 1152 1153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
 HDAC-dependent repression of Dnmt1 transcription. (A) Northern blot showing expression of Dnmt1 mRNA in NIH 3T3 cells 24 h after addition of TSA at the indicated concentrations. Ten micrograms of total RNA were analyzed. (B) Western blot analysis reveals protein levels in NIH 3T3 cells treated with TSA. Twenty micrograms of WCE were subjected to western blot analysis with the indicated antibodies. (C) Cell cycle distribution of NIH 3T3 cells 24 h after addition of TSA at indicated concentrations. DNA content was measured by flow cytometry. (D) Effect of TSA on the activity of the Dnmt1 core promoter region at G0/G1 phase. NIH 3T3 cells were transfected with 300-luc (columns 1 and 6), 300 A-luc (columns 2 and 7), 300 C-luc (columns 3 and 8), 300 AC-luc (columns 4 and 9) or No insert-luc (columns 5 and 10). Twenty-four hours later, cells were growth-arrested by serum starvation for 36 h. Cells were subsequently treated with or without TSA (200 nM) for 24 h before luciferase activity was determined. Luciferase activity is normalized to Renilla luciferase activity and is shown relative to No insert-luc transfections (columns 5 and 10). (E) Effect of TSA on growth-arrested cells. Prior to flow cytometry, NIH 3T3 cells were serum starved for 36 h, and then treated with (+TSA) or without (-TSA) 200 nM TSA for 24 h. Asyn, asynchronized NIH 3T3 cells.
###end p 85
###begin p 86
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 522 529 522 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 245 249 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 The E2F-Rb-HDAC complex decreases the promoter activity of mouse Dnmt1. Saos-2 cells were co-transfected with the plasmids indicated in the figure. The ratio of luciferase reporter plasmid, E2F-1 expression vector, Rb expression vector and pRL-SV40 internal control vector was 10:10:60:1. TSA was added 24 h after transfection. TSA (+) and TSA (++) indicate treatment with concentrations of 100 and 200 nM, respectively. Luciferase activity was determined 48 h post-transfection. The luciferase counts were normalized to Renilla luciferase activity. The standard luciferase activity (100%) was defined as that of cells transfected with the 300-luc and empty expression vectors (column 1).
###end p 86
###begin p 87
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 270 271 270 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 273 274 273 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 481 482 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmt1</italic>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
 A proposed model for the regulatory mechanisms of mouse Dnmt1 transcription. At all stages of the cell cycle, there is basal level expression of Dnmt1 driven by site A. The E2F site alters transcription by different means, depending on the phase of the cell cycle. At G0/G1 phase Rb can bind to E2F, recruiting HDAC to the complex, resulting in repression of transcription of Dnmt1. A transcription factor bound to site A (TFBA) maintains low transcriptional levels of Dnmt1. At G1/S phase, the inhibition of Dnmt1 transcription mediated by the E2F site is released, and E2F and TFBA now work cooperatively to increase the expression levels in a regulated manner.
###end p 87
###begin title 88
ACKNOWLEDGEMENTS
###end title 88
###begin p 89
We thank Drs J. Rossant, M. Yoshida and T. Yamamoto for reagents and Drs K. Ohtani, H. Yamaguchi and K. Imakawa for reagents and helpful advice on EMSA. We also thank Dr Jared Ordway for helpful comments and appreciate proofreading by David Benhayon. This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) (K.S.) and the Japan Society for the Promotion of Science (H.K.).
###end p 89
###begin title 90
REFERENCES
###end title 90

